Gyroscope Theraputics secures £50.4m Series B financing
Syncona and Cambridge Innovation Capital will contribute £48 million and £2.4 million, respectively.
Read More
Tag: Gyroscope
Gyroscope and Orbital to create retinal gene therapy company
The two units belong to Sycona, who will own 82% of the company.
Read More
